Re-evaluation of the molecular pharmacology of mitomycin C
- 30 November 1995
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 31 (12), 1928-1933
- https://doi.org/10.1016/0959-8049(95)00364-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Solution Structure of the Monoalkylated Mitomycin C–DNA ComplexJournal of Molecular Biology, 1995
- Unusually marked hypoxic sensitization to indoloquinone E09 and mitomycin C in a human colon‐tumour cell line that lacks DT‐diaphorase activityInternational Journal of Cancer, 1994
- Sequence-selective alkylation and cross-linking induced by mitomycin C upon activation by DT-diaphoraseBiochemistry, 1993
- Relevance of DT‐diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: Differences in in vitro and in vivo systemsInternational Journal of Cancer, 1993
- DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone familyCarcinogenesis: Integrative Cancer Research, 1991
- Mechanism of monofunctional and bifunctional alkylation of DNA by mitomycin CBiochemistry, 1988
- Reductive activation of mitomycin CBiochemistry, 1988
- Autocatalytic quinone methide formation from mitomycin cBiochemistry, 1986
- Chemical modification of DNA with muta-carcinogens. III. Reductive alkylation of DNA with mitomycin C.Environmental Health Perspectives, 1985
- Reductive metabolism and alkylating activity of mitomycin C induced by rat liver microsomesBiochemistry, 1981